Use of a margarine fortified with n-3 fatty acids significantly reduced post-myocardial infarction ventricular arrhythmia-related events by 84% among diabetic patients….
Read More »Yearly Archives: 2011
Treating Prehypertension Reduces Risk of Stroke by 22 Percent
Patients with prehypertension who take blood pressure-lowering therapy have a highly statistically significant 22% reduced risk for stroke….
Read More »Genetic Disorder Leads to Diabetes Therapy
Clues to development of the pancreas provided by rare genetic disorder could lead to diabetes therapy.…
Read More »GLP-1 Lixisenatide Phase III Results
Adding lixisenatide to metformin and insulin glargine significantly reduced glycated hemoglobin levels and improved post-prandial glucose in patients with type 2 diabetes….
Read More »Antihypertensive Drugs More Effective When Taken at Night
Taking antihypertensive medications at bedtime rather than in the morning has been shown to be associated with an increase in bedtime BP decline toward a dipping pattern and better BP control and reduction in urinary protein excretion….
Read More »Editor’s Note: AGEs, Errors and Teenagers
Over the past three issues we have focused on advanced glycation end-products (AGEs) — how they are formed, what they can do, and why these compounds are detrimental to our patients’ health. This week in our Homerun Slides, we are bringing you information on ways to reduce the effects of …
Read More »Psychology in Diabetes Care, 2nd Ed, Part 8: Diabetes in Adolescents
Edited by Frank J. Snoek and T. Chas Skinner Diabetes in Adolescents 2.1 Introduction There is no widely accepted precise definition of what adolescence is, but it is commonly referred to as the transitional period between childhood and adulthood.
Read More »Overview of AGEs, Part 4 of 4
This week we wrap-up our four-part series of Homerun Slides covering AGEs, with slides on Supplements, Pharmacological Agents Under Investigation, More Common Pharmacological Agents, and Metabolic Activation Therapy (MAT)….
Read More »Letter from the Editor: New GLP-1 Article
We have been sharing a lot of information about native GLP-1 and GLP-1 analogs, and how these compounds work to control glucose levels in our patients. Lately there has been a lot of press concerning the possible cardiovascular benefits of using these analogs in our patients. We’ve been able to …
Read More »GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1
Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO Cardiovascular disease is a leading cause of death in the United States and across the world, and better therapies are constantly being sought to improve patient outcomes. Recent studies have brought …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.